{"id":688766,"date":"2022-09-26T08:34:23","date_gmt":"2022-09-26T12:34:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/"},"modified":"2022-09-26T08:34:23","modified_gmt":"2022-09-26T12:34:23","slug":"neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/","title":{"rendered":"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform"},"content":{"rendered":"<h2>\nUpgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need of treatment<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">MALVERN, Pa., Sept.  26, 2022  (GLOBE NEWSWIRE) &#8212; <strong>\u00a0<\/strong>Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced upgrades today to the TrakStar\u00ae platform that will offer all NeuroStar\u00ae providers a more turnkey patient management experience.\u00a0\u00a0 Continuing Neuronetics\u2019 commitment to innovation, this release represents the third TrakStar upgrade in 2022.<\/p>\n<p>\u201cWe continue to innovate our TrakStar platform to be a smarter, better tool,\u201d stated Keith J. Sullivan, President, and CEO of Neuronetics Inc. \u201cThe latest updates can streamline the patient journey by bridging our proprietary PHQ-10 platform with our HIPAA-compliant TrakStar patient data management system making it easier to identify new patients and those needing re-treatment. We value our NeuroStar providers and the vital work they do to help people suffering from drug-resistant depression, so it\u2019s important to us to provide the best and most up-to-date tools to help them find and reach people who need help more quickly.\u201d<\/p>\n<p>The TrakStar upgrades also include a simplified interface to quickly sort and prioritize potential patients with ease. NeuroStar\u2019s exclusive PHQ-10 tool, launched in early 2022, generates new patient candidates which are automatically loaded into TrakStar. To streamline the benefits investigation (BI) process, the BI results automatically appear in TrakStar and can be converted to a NeuroStar patient with the click of a button. Additional TrakStar advances include reporting updates to highlight patients who have not completed prescribed treatment or who may need re-treatment, a revamped tutorial page, and new clinical outcomes scores which can be automatically e-mailed to patients with customizable templates.<\/p>\n<p>\u201cThe level of support NeuroStar provides by ensuring we, as clinicians, have the most advanced tools to do our job most effectively and efficiently is incredible,\u201d said Dr. Kenneth Pages, TMS of South Tampa. \u201cThese new enhancements to TrakStar improve our lead management capabilities by automating and simplifying the process of identifying and converting patients. This allows us to help more patients suffering from neurohealth conditions like depression.\u201d<\/p>\n<p>The TrakStar upgrades are available now for all NeuroStar providers. For more information about NeuroStar, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N8SZcQxsmuIqQuw_Dc--mDGttTG7m_QSjdMC1c6mYGyXbkdjknQiYWD67ymhqGI1MtHyAhfpu5w1YPvZNAxEog==\" rel=\"nofollow noopener\" target=\"_blank\">neurostar.com<\/a>.<\/p>\n<p>\n        <strong>About<\/strong><br \/>\n        <strong>Neuronetics<\/strong><br \/>\n        <br \/>Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn\u2019t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 4.8 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world\u2019s largest depression Outcomes Registry. Neuronetics is committed to transforming lives by offering an exceptional treatment that produces extraordinary results. For safety and prescribing information, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WihkpKatu2zu2QouqDot4PGM5munvUtFZdPOP5DdWEgUB4q4bC4NPcEkshNTZB2Jk6dyobCW6gDVEtu4snINEQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.neurostar.com<\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>EvolveMKD<br \/>646.517.4220<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_LE-mtF4aKd9hReMsY5pH1t5R8PYn1VsM0H0btfrTorIR6eTgHI00brtEOgO4ZcOX3aos6YMhT4wtemAKt8xER5hMRX1MS_CKkpVc5rwtd0=\" rel=\"nofollow noopener\" target=\"_blank\">NeuroStar@evolvemkd.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODNkZWJjZDEtZjFhMS00MzM5LTkyNjUtZTI1NjdiZDU3OTcxLTExMjIwMTE=\/tiny\/Neuronetics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Upgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need of treatment MALVERN, Pa., Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; \u00a0Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced upgrades today to the TrakStar\u00ae platform that will offer all NeuroStar\u00ae providers a more turnkey patient management experience.\u00a0\u00a0 Continuing Neuronetics\u2019 commitment to innovation, this release represents the third TrakStar upgrade in 2022. \u201cWe continue to innovate our TrakStar platform to be a smarter, better tool,\u201d stated Keith J. Sullivan, President, and CEO of Neuronetics Inc. \u201cThe latest &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-688766","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Upgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need of treatment MALVERN, Pa., Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; \u00a0Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced upgrades today to the TrakStar\u00ae platform that will offer all NeuroStar\u00ae providers a more turnkey patient management experience.\u00a0\u00a0 Continuing Neuronetics\u2019 commitment to innovation, this release represents the third TrakStar upgrade in 2022. \u201cWe continue to innovate our TrakStar platform to be a smarter, better tool,\u201d stated Keith J. Sullivan, President, and CEO of Neuronetics Inc. \u201cThe latest &hellip; Continue reading &quot;Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-26T12:34:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform\",\"datePublished\":\"2022-09-26T12:34:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/\"},\"wordCount\":561,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/\",\"name\":\"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=\",\"datePublished\":\"2022-09-26T12:34:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/","og_locale":"en_US","og_type":"article","og_title":"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform - Market Newsdesk","og_description":"Upgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need of treatment MALVERN, Pa., Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; \u00a0Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced upgrades today to the TrakStar\u00ae platform that will offer all NeuroStar\u00ae providers a more turnkey patient management experience.\u00a0\u00a0 Continuing Neuronetics\u2019 commitment to innovation, this release represents the third TrakStar upgrade in 2022. \u201cWe continue to innovate our TrakStar platform to be a smarter, better tool,\u201d stated Keith J. Sullivan, President, and CEO of Neuronetics Inc. \u201cThe latest &hellip; Continue reading \"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-26T12:34:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform","datePublished":"2022-09-26T12:34:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/"},"wordCount":561,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/","name":"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=","datePublished":"2022-09-26T12:34:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MjQ4MCM1MTY5MjkwIzIxMTA0NDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuronetics-launches-innovations-to-neurostar-advanced-therapys-proprietary-trakstar-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Neuronetics Launches Innovations To NeuroStar\u00ae Advanced Therapy\u2019s Proprietary TrakStar\u00ae Platform"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=688766"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688766\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=688766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=688766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=688766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}